Findings

What do systematic reviews say?

292 questions · 304 findings · 22 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 72 · 23.7%GRADE not reported 48 · 15.8%Very low 61 · 20.1%Low 94 · 30.9%Moderate 29 · 9.5%High 0 · 0%

TongXingLuo vs Western medicine

Cognitive function · People with vascular dementia

2 findings from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 180 participants
Moderate
Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

TongXingLuo vs Western medicine

Cognition‐ADAS‐Cog ‐ not measured · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

TongXingLuo vs Western medicine

Global performance (improved) · People with vascular dementia

TongXingLuo showed no clear difference in global performance (improved) compared with western medicine (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RR 1.26 [1, 1.6]
2 studies · 180 participants
Low

TongXingLuo vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

TongXingLuo showed no clear difference in adverse events (AEs) (1 or more) compared with western medicine (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 180 participants
Low

TongXingLuo vs Western medicine

Activities of daily living · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

TongXingLuo vs Western medicine

Behaviour ‐ only measured in one study · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Equity of distribution of dentists post implementation (Gini coefficient) · Western medicine physicians, Chinese medicine physicians and dentists

1 finding from 1 review

Interventions for increasing the proportion of health professionals practising in rural and other underserved areas 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 6 participants
Very low

STW5 (Iberogast) vs placebo

Global symptoms of dyspepsia · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 814 participants
Very low

Curcuma longa vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

Curcuma longa may leads to higher global symptoms of dyspepsia (responders) compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.5 [1.06, 2.11]
1 study · 76 participants
Low

Curcuma longa vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

Curcuma longa showed no clear difference in adverse events Assessed clinically compared with placebo (moderate certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.26 [0.51, 3.08]
1 study · 89 participants
Moderate

Curcuma longa vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 89 participants
Moderate

STW5 (Iberogast) vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

STW5 (Iberogast) showed no clear difference in global symptoms of dyspepsia (responders) compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.55 [0.98, 2.47]
2 studies · 324 participants
Low

STW5 (Iberogast) vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

STW5 (Iberogast) showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 0.92 [0.52, 1.64]
4 studies · 786 participants
Low

STW5 (Iberogast) vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 52 participants
Low

Peppermint/caraway oil vs placebo

Global symptoms of dyspepsia · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 210 participants
Moderate

Peppermint/caraway oil vs placebo

Global symptoms of dyspepsia (responders) · patients with functional dyspepsia

Peppermint/caraway oil probably leads to higher global symptoms of dyspepsia (responders) compared with placebo (moderate certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.53 [1.3, 1.81]
3 studies · 305 participants
Moderate

Peppermint/caraway oil vs placebo

Adverse events Assessed clinically · patients with functional dyspepsia

Peppermint/caraway oil showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
RR 1.56 [0.69, 3.53]
3 studies · 305 participants
Low

Peppermint/caraway oil vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 99 participants
Moderate

Curcuma longa vs placebo

Global symptoms of dyspepsia · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 110 participants
Moderate

FuFangDanShen vs 'no treatment'

Cognitive function · People with vascular dementia

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 95 participants
Low